FDC Quarterly Results for Trading Insights

FDC • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹28 Cr
QSept 2025
Quarterly Results

FDC Quarterly Results Key Highlights

  • Revenue of ₹494 Cr in Sept 2025 (-2.8% vs Mar 2025, -10.0% vs Sept 2024)
  • Net Profit of ₹28 Cr in Sept 2025 (-28.2% vs Mar 2025, -61.1% vs Sept 2024)
  • EBITDA of ₹54 Cr in Sept 2025 (-22.9% vs Mar 2025)
  • Operating Margin of 7.0% in Sept 2025 (-4.0pp vs Mar 2025)
  • Earnings Per Share of ₹1.75 in Sept 2025 (-26.5% vs Mar 2025)

FDC Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 494 508 684 486 549 -2.8% -10.0%
Net Profit (₹ Cr) 28 39 121 28 72 - -
EBITDA (₹ Cr) 54 70 176 52 105 - -
EPS (₹) 1.75 2.38 7.45 1.74 4.43 - -
Operating Margin (%) 7.0% 11.0% 22.0% 7.0% 14.0% - -

FDC Share Price Trend Around Quarterly Results

Visualize FDC's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for FDC

Additional stock information and data for FDC

FDC share price
FDC price earnings ratio
FDC 52-week performance

Profitability Ratios

Profit Margin 5.7%
EBITDA Margin 10.9%
Operating Margin 7.0%
ROE (Annual) 4.9%

Balance Sheet Highlights

Total Assets ₹2,714 Cr
Total Equity ₹2,281 Cr
Current Assets ₹1,089 Cr
Current Liabilities ₹71 Cr

Cash Flow Analysis

Operating Cash Flow ₹318 Cr
Investing Cash Flow ₹-199 Cr
Financing Cash Flow ₹-92 Cr
Net Cash Flow ₹26 Cr

Current Market Data

Current Price ₹345.85
Exchange NSE
Last Updated Apr 08, 2026

Revenue Trend (₹ Cr)

Dec 2025 486
Jun 2025 684
Mar 2025 508
Sept 2025 494

Net Profit Trend (₹ Cr)

Dec 2025 28
Jun 2025 121
Mar 2025 39
Sept 2025 28

Operating Margin Trend (%)

Dec 2025 7.0%
Jun 2025 22.0%
Mar 2025 11.0%
Sept 2025 7.0%

Sector Competitors - Quarterly Performance Comparison

Comparing FDC quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1714.6 14,875 3,125 +10.8% - 21.0% 131.9
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5882.0 2,860 689 +7.1% - 24.1% 226.5
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4029.2 3,219 591 +11.3% - 18.4% 229.7
Lupin
Sept 2025 		₹102,578.78 Cr 2294.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1191.4 9,135 1,337 +1.1% - 14.6% 73.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores